Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells

Inclusion Criteria: * Age between 18 and 70 years * Patients who will be subjected to programmed anatomic lung resection (pneumonectomy excluded) * Patients class C or D on the risk scale of air leak Patients included in the study must meet all inclusion criteria. Exclusion Criteria: Patients with any of the following exclusion criteria may not be included in the clinical trial: * Those considered by the investigator are not on a good position to tolerate the procedure * Clinical criteria and anesthetics that contraindicate surgery * Uncontrolled severe disease * Pregnant women * Patients infected with hepatitis B, hepatitis C, syphilis and HIV + virus * People who are taking a drug under clinical investigation or participated in any study under clinical investigation (or an authorized product) within 30 days prior to randomization * The absence of informed consent or revocation thereof